These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15921709)

  • 1. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.
    Darmani NA; McClanahan BA; Trinh C; Petrosino S; Valenti M; Di Marzo V
    Neuropharmacology; 2005 Sep; 49(4):502-13. PubMed ID: 15921709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
    Suplita RL; Gutierrez T; Fegley D; Piomelli D; Hohmann AG
    Neuropharmacology; 2006 Mar; 50(3):372-9. PubMed ID: 16316669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol.
    Ho WS; Randall MD
    Br J Pharmacol; 2007 Mar; 150(5):641-51. PubMed ID: 17245358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels.
    de Lago E; Petrosino S; Valenti M; Morera E; Ortega-Gutierrez S; Fernandez-Ruiz J; Di Marzo V
    Biochem Pharmacol; 2005 Aug; 70(3):446-52. PubMed ID: 15963472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
    Darmani NA; Crim JL
    Pharmacol Biochem Behav; 2005 Jan; 80(1):35-44. PubMed ID: 15652378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.
    Darmani NA
    J Pharmacol Exp Ther; 2002 Jan; 300(1):34-42. PubMed ID: 11752094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis.
    Darmani NA
    J Neural Transm (Vienna); 1998; 105(10-12):1143-54. PubMed ID: 9928884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew).
    Darmani NA; Zhao W; Ahmad B
    J Neural Transm (Vienna); 1999; 106(11-12):1045-61. PubMed ID: 10651102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells.
    Winkler K; Ramer R; Dithmer S; Ivanov I; Merkord J; Hinz B
    Oncotarget; 2016 Mar; 7(12):15047-64. PubMed ID: 26930716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin causes over-expression of tachykinin NK(1) receptors and increases ERK1/2- and PKA- phosphorylation during peak immediate- and delayed-phase emesis in the least shrew (Cryptotis parva) brainstem.
    Darmani NA; Dey D; Chebolu S; Amos B; Kandpal R; Alkam T
    Eur J Pharmacol; 2013 Jan; 698(1-3):161-9. PubMed ID: 23001014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew).
    Parker LA; Limebeer CL; Rock EM; Litt DL; Kwiatkowska M; Piomelli D
    Physiol Behav; 2009 Apr; 97(1):121-4. PubMed ID: 19239915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pivotal role of glycogen synthase kinase 3 (GSK-3) in vomiting evoked by specific emetogens in the least shrew (Cryptotis parva).
    Zhong W; Darmani NA
    Neurochem Int; 2020 Jan; 132():104603. PubMed ID: 31738972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Zhong W; Trinh C; McClanahan B; Brar RS
    Eur J Pharmacol; 2014 Jan; 722():147-55. PubMed ID: 24157976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus.
    Sticht MA; Rock EM; Parker LA
    Physiol Behav; 2013 Aug; 120():228-32. PubMed ID: 23958470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAAH and anandamide: is 2-AG really the odd one out?
    Di Marzo V; Maccarrone M
    Trends Pharmacol Sci; 2008 May; 29(5):229-33. PubMed ID: 18394720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake?
    Fowler CJ; Ghafouri N
    Pharmacol Res; 2008 Jul; 58(1):72-6. PubMed ID: 18675915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of (R)-2-(2-Fluorobiphenyl-4-yl)-N-(3-Methylpyridin-2-yl)Propanamide as a Dual Fatty Acid Amide Hydrolase: Cyclooxygenase Inhibitor.
    Gouveia-Figueira S; Karlsson J; Deplano A; Hashemian S; Svensson M; Fredriksson Sundbom M; Congiu C; Onnis V; Fowler CJ
    PLoS One; 2015; 10(9):e0139212. PubMed ID: 26406890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).
    Darmani NA; Chebolu S; Amos B; Alkam T
    Pharmacol Biochem Behav; 2011 Oct; 99(4):573-9. PubMed ID: 21683089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
    John CS; Currie PJ
    Behav Brain Res; 2012 Aug; 233(2):382-8. PubMed ID: 22633963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.